Arcutis Biotherapeutics Inc (ARQT)
10.02
-0.16
(-1.52%)
USD |
NASDAQ |
Oct 04, 16:00
10.02
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Shareholders Equity (Annual): 88.67M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.67M |
| December 31, 2022 | 209.58M |
| December 31, 2021 | 297.68M |
| December 31, 2020 | 270.62M |
| Date | Value |
|---|---|
| December 31, 2019 | -65.03M |
| December 31, 2018 | -23.99M |
| December 31, 2017 | -4.993M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-65.03M
Minimum
2019
297.68M
Maximum
2021
160.30M
Average
209.58M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Madrigal Pharmaceuticals Inc | 405.33M |
| Heron Therapeutics Inc | -33.97M |
| Zevra Therapeutics Inc | 61.86M |
| Axsome Therapeutics Inc | 190.98M |
| Mirum Pharmaceuticals Inc | 248.67M |